Deloitte November 30, 2018
The medtech industry is under pressure: From tight margins and the shift to value-based payment models to advances in digital technology, many R&D leaders are taking a fresh look at investment strategies.
Executive summary
MOST medtech companies are under pressure to improve efficiency and reduce costs in an environment where health systems, patients, and payers require increasing levels of evidence to justify product value and reimbursement. At the same time, innovation in payment models and advances in sensors and digital technologies are creating new opportunities to advance patient care and improve development efficiency. Technology advances can also create competitive threats from nontraditional entrants.
The key findings from the survey are:
- R&D leaders are responding to...